Related Experiment Video
Updated: Jun 25, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
LI-RADS radiation-based treatment response algorithm for HCC: what to know and how to use it
Carla Harmath1, Alice Fung2, Anum Aslam3
1University of Chicago, Chicago, USA. charmath@bsd.uchicago.edu.
The LI-RADS TR algorithm was updated to better assess treatment response in hepatocellular carcinoma (HCC) after radiation therapies. This revised approach accounts for unique post-treatment liver changes, improving accuracy in evaluating therapy effectiveness.
Area of Science:
- Hepatobiliary imaging
- Interventional oncology
- Radiology
Background:
- Locoregional treatments (LRT) for hepatocellular carcinoma (HCC) are evolving, with increasing use of radiation-based therapies like selective internal radiation therapy (SIRT), transarterial radioembolization (TARE), external beam radiation therapy (EBRT), and stereotactic body radiation therapy (SBRT).
- Assessing treatment response after these therapies is complex due to treatment-related liver changes, inflammation, and variable response timelines.
- The initial LI-RADS treatment response (LR-TR) algorithm, developed in 2017, encompassed all LRT, but lacked specificity for radiation-based modalities.
Purpose of the Study:
- To elucidate the changes in the updated LI-RADS TR algorithm specifically for radiation-based LRT in HCC.
- To provide a guide for utilizing the revised LR-TR algorithm.
- To illustrate expected and unexpected imaging findings following liver-directed therapies for HCC.
Main Methods:
- Review and analysis of the updated LI-RADS TR algorithm focusing on radiation-based therapies.
- Comparison of imaging patterns between radiation and non-radiation based therapies.
- Case-based illustration of imaging findings post-treatment.
Main Results:
- The updated LR-TR algorithm incorporates specific criteria to differentiate tumor response from treatment-related changes after radiation therapies.
- Recognizes distinct imaging patterns associated with SIRT, TARE, EBRT, and SBRT.
- Aims to improve the accuracy and consistency of treatment response assessment in HCC.
Conclusions:
- The revised LI-RADS TR algorithm offers a more nuanced approach to evaluating treatment response in HCC following radiation-based LRT.
- Accurate assessment is crucial for guiding subsequent management decisions in HCC patients.
- Understanding these updated guidelines aids radiologists in interpreting post-treatment imaging findings.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024